Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity.
Lv D, Pal P, Liu X, Jia Y, Thummuri D, Zhang P, Hu W, Pei J, Zhang Q, Zhou S, Khan S, Zhang X, Hua N, Yang Q, Arango S, Zhang W, Nayak D, Olsen SK, Weintraub ST, Hromas R, Konopleva M, Yuan Y, Zheng G, Zhou D.
Lv D, et al. Among authors: hua n.
Nat Commun. 2021 Nov 25;12(1):6896. doi: 10.1038/s41467-021-27210-x.
Nat Commun. 2021.
PMID: 34824248
Free PMC article.